PATENT CLAIM ANALYSIS

Application Number: 15757696
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-06
Patent Classification: ["514", "04400A"]

Abstract:
The present invention relates to the serine threonine kinase 32C (STK32C) gene relevant to breast cancer and a use thereof, and particularly, to a composition for the diagnosis, prevention, or treatment of breast cancer using the STK32C gene. In the present invention, changes in breast cancer cells according to STK32C gene expression differences were identified, and a breast cancer inhibitory effect according to the inhibition of expression of the STK32C gene and YB-1, which is a substrate protein, were newly verified, and thus target therapies are expected in treatment of breast cancer through more fundamental approaches.

Claim (Index 9):
The method of  claim 7 , wherein the measuring of the expression or activity degree of STK32C is performed by measuring a phosphorylation degree of YB-1 by STK32C.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.81667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13030860', '15617788', '13027038', '14798208', '15075373']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7365361132621532
- 35 USC 102 Novelty (BERT): 0.5390269127017197
- Combined Prediction Score: 0.7167851932061099
- Mean Citation Score: 298.24408
- Max Citation Score: 302.55
- Similarity Product: 132.50961256474258

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test